BlackRock Health Sciences Trust — Director's Dealing 2021

Feb 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BlackRock Health Sciences Trust (BME)
CIK: 0001314966
Period of Report: 2021-01-29

Reporting Person: Accettella Christopher (Portfolio Manager)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-29	Common Stock	M	227.8706	—	Acquired	876.9926	Direct
2021-01-29	Common Stock	D	227.8706	$47.88	Disposed	649.122	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-29	Phantom Shares	$	A	174.9165	Acquired		Common Stock (174.9165)	Direct
2021-01-29	Phantom Shares	$	M	60.483	Disposed		Common Stock (60.483)	Direct
2021-01-29	Phantom Shares	$	M	74.0812	Disposed		Common Stock (74.0812)	Direct
2021-01-29	Phantom Shares	$	M	93.3063	Disposed		Common Stock (93.3063)	Direct

Footnotes

F1: A phantom share is the economic equivalent of one share of common stock and, subject to the applicable vesting requirements, becomes payable in cash.

F2: As previously reported on a Form 4 dated February 4, 2020, the Reporting Person was granted phantom shares on January 31, 2020 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.

F3: As previously reported on a Form 4 dated February 4, 2019, the Reporting Person was granted phantom shares on January 31, 2019 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.

F4: As previously reported on a Form 4 dated February 2, 2018, the Reporting Person was granted phantom shares on January 31, 2018 payable in cash on vesting, which occurs in equal installments on each of the first three anniversaries of the grant date.

F5: These phantom shares vest in equal installments on each of the first three anniversaries of the award.